Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two versus three doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy
ISRCTN74189211Phase 4Completed
- Sponsor
- Dirección Nacional de Salud
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by Dirección Nacional de Salud. Primary endpoint: Placental malaria. Started Apr 2006; status: completed.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN74189211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74189211.